In NOD mice, weekly injections of many different TLR ligands, including poly(I:C) (TLR3 agonist), LPS (TLR4 agonist), or P40 protein from Klebsiella (TLR2 agonist), can block diabetes development if started at weaning (116). Here, TLR4 is linked to diabetes mellitus.